Literature DB >> 26708109

Design and synthesis of novel Y-shaped barbituric acid derivatives as PPARγ activators.

Vaibhav A Dixit1, Prakash Chandra Rathi2, Shweta Bhagat1, Holger Gohlke2, Rasmus K Petersen3, Karsten Kristiansen3, Asit K Chakraborti1, Prasad V Bharatam4.   

Abstract

Novel Y-shaped barbituric acid (BA) derivatives have been designed using rational methods including molecular docking. Fourteen novel compounds were synthesized using hydroxyl group protection-deprotection strategies for PPARγ activation. Competitive binding analysis of the synthesized molecules using time-resolved fluorescence resonance energy transfer (FRET) method was carried out, and the IC50 values were determined. The symmetrically substituted derivatives have shown greater binding affinity than unsymmetrically substituted derivatives. Nitrobenzyl and cyanophenyl substituted derivatives have shown reasonable binding affinities (10.1 and 6.5 μM, respectively), while mono and diacetate derivatives were found inactive. Molecular dynamics simulations show that the designed compounds have interaction profiles similar to partial agonists. The most significant finding of our study is that BA derivatives with symmetrically substituted weakly polar side chains result in the desired moderate level of PPARγ binding affinities.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-diabetic agents; Barbituric acid derivatives; Competitive binding; PPARγ activation; Y-shaped ligands

Mesh:

Substances:

Year:  2015        PMID: 26708109     DOI: 10.1016/j.ejmech.2015.11.030

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Type II diabetes mellitus and obesity: Common links, existing therapeutics and future developments.

Authors:  Subhadeep Banerjee; Indrani Talukdar; Arnab Banerjee; Arnav Gupta; Advait Balaji; Raviprasad Aduri
Journal:  J Biosci       Date:  2019-12       Impact factor: 1.826

2.  Structural Basis for the Enhanced Anti-Diabetic Efficacy of Lobeglitazone on PPARγ.

Authors:  Jun Young Jang; Hwan Bae; Yong Jae Lee; Young Il Choi; Hyun-Jung Kim; Seung Bum Park; Se Won Suh; Sang Wan Kim; Byung Woo Han
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

3.  Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase.

Authors:  Jirawat Riyaphan; Chien-Hung Jhong; Shian-Ren Lin; Chia-Hsiang Chang; May-Jwan Tsai; Der-Nan Lee; Ping-Jyun Sung; Max K Leong; Ching-Feng Weng
Journal:  Molecules       Date:  2018-09-05       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.